HomeAI · summaries
Storia in 2 fonti
CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy
MUNICH — CRISPR Therapeutics’ gene editing candidate showed mixed durability results a year after patients were dosed, according to early-stage data presented Friday at the annual meeting of the European Society ...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy
MUNICH — CRISPR Therapeutics’ gene editing candidate showed mixed durability results a year after patients were dosed, according to early-stage data presented Friday at the annual…
- ·
time.com
A One-Time Treatment for High Cholesterol Shows Promising Results
A CRISPR-based gene-editing therapy could be a one-and-done treatment for high cholesterol and high triglycerides, a study suggests.